Search
anti-Staphylococcal vaccine
Protein-conjugated vaccine incorporating capsular polysaccharides from the 2 most common Staphylococcus aureus isolates.
Staphylococcal polysaccharides are poor antigens.
57% reduction in Staphylococcal bacteremia in immunized dialysis patients 3-40 weeks after immunization. No reduction after 1 or 2 years. Antibody levels are consistent with clinical findings.
Related
polysaccharide (complex carbohydrate, glycan)
Staphylococcus aureus
General
vaccine
References
Robbins JB, Schneerson R, Horwith G, Naso R, Fattom A.
Staphylococcus aureus types 5 and 8 capsular polysaccharide-
protein conjugate vaccines.
Am Heart J. 2004 Apr;147(4):593-8.
PMID: 15077073